Literature DB >> 33452282

The ISN/RPS 2016 classification predicts renal prognosis in patients with first-onset class III/IV lupus nephritis.

Asaka Hachiya1, Munetoshi Karasawa1, Takahiro Imaizumi1,2, Noritoshi Kato1, Takayuki Katsuno3, Takuji Ishimoto1, Tomoki Kosugi1, Naotake Tsuboi4, Shoichi Maruyama5.   

Abstract

Lupus nephritis (LN) is a life-threatening complication of systemic lupus erythematosus. The 2003 pathological classification of LN was revised in 2016; it quantitatively evaluates the interstitium in addition to the glomeruli. We performed a retrospective multi-centre cohort study and investigated the utility of the 2016 classification-including the activity index (AI), chronicity index (CI), and each pathological component to predict complete remission or renal function decline, defined as 1.5-fold increase in serum creatinine levels-and compare with that of the 2003 classification. Ninety-one consecutive adult patients with first-onset class III/IV LN who were newly prescribed any immunosuppressants were enrolled and followed up for a median of 51 months from January 2004. Cox regression analysis demonstrated the subclasses based on the 2003 classification, which mainly evaluate glomerular lesions, were not associated with clinical outcomes. After adjustments for estimated glomerular filtration rate and urinary protein levels, higher CI and higher interstitial fibrosis and lower hyaline deposit scores were associated with renal functional decline. Similarly, higher CI and interstitial inflammation scores were associated with failure to achieve complete remission. Therefore, the 2016 classification can predict the clinical outcomes more precisely than the 2003 classification.

Entities:  

Year:  2021        PMID: 33452282      PMCID: PMC7810677          DOI: 10.1038/s41598-020-78972-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  33 in total

1.  Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data.

Authors:  H A Austin; D T Boumpas; E M Vaughan; J E Balow
Journal:  Kidney Int       Date:  1994-02       Impact factor: 10.612

2.  Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring.

Authors:  Christine Hsieh; Anthony Chang; Daniel Brandt; Riteesha Guttikonda; Tammy O Utset; Marcus R Clark
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-06       Impact factor: 4.794

3.  Interobserver reproducibility and application of the ISN/RPS classification of lupus nephritis-a UK-wide study.

Authors:  Peter N Furness; Nick Taub
Journal:  Am J Surg Pathol       Date:  2006-08       Impact factor: 6.394

4.  Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort.

Authors:  Maria I Danila; Guillermo J Pons-Estel; Jie Zhang; Luis M Vilá; John D Reveille; Graciela S Alarcón
Journal:  Rheumatology (Oxford)       Date:  2009-02-20       Impact factor: 7.580

5.  Histological predictors of renal outcome in lupus nephritis: the importance of tubulointerstitial lesions and scoring of glomerular lesions.

Authors:  B Obrișcă; R Jurubiță; A Andronesi; B Sorohan; C Achim; R Bobeica; M Gherghiceanu; E Mandache; G Ismail
Journal:  Lupus       Date:  2018-05-14       Impact factor: 2.911

6.  Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization.

Authors:  G B Appel; D J Cohen; C L Pirani; J I Meltzer; D Estes
Journal:  Am J Med       Date:  1987-11       Impact factor: 4.965

Review 7.  Update on Lupus Nephritis.

Authors:  Salem Almaani; Alexa Meara; Brad H Rovin
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-07       Impact factor: 8.237

8.  Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome.

Authors:  H A Austin; L R Muenz; K M Joyce; T T Antonovych; J E Balow
Journal:  Kidney Int       Date:  1984-04       Impact factor: 10.612

9.  Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.

Authors:  Gerald B Appel; Gabriel Contreras; Mary Anne Dooley; Ellen M Ginzler; David Isenberg; David Jayne; Lei-Shi Li; Eduardo Mysler; Jorge Sánchez-Guerrero; Neil Solomons; David Wofsy
Journal:  J Am Soc Nephrol       Date:  2009-04-15       Impact factor: 10.121

10.  Early achievement of deep remission predicts low incidence of renal flare in lupus nephritis class III or IV.

Authors:  Hironari Hanaoka; Harunobu Iida; Tomofumi Kiyokawa; Yukiko Takakuwa; Kimito Kawahata
Journal:  Arthritis Res Ther       Date:  2018-05-02       Impact factor: 5.156

View more
  3 in total

1.  Beyond ISN/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival.

Authors:  Gabriella Moroni; Giulia Porata; Francesca Raffiotta; Silvana Quaglini; Giulia Frontini; Lucia Sacchi; Valentina Binda; Marta Calatroni; Francesco Reggiani; Giovanni Banfi; Claudio Ponticelli
Journal:  Kidney360       Date:  2021-11-05

2.  Utility of the 2018 revised ISN/RPS thresholds for glomerular crescents in childhood-onset lupus nephritis: a Pediatric Nephrology Research Consortium study.

Authors:  Pooja Patel; Marietta de Guzman; M John Hicks; Joseph G Maliakkal; Michelle N Rheault; David T Selewski; Katherine Twombley; Jason M Misurac; Cheryl L Tran; Alexandru R Constantinescu; Ali M Onder; Meredith Seamon; Wacharee Seeherunvong; Vaishali Singh; Cynthia Pan; Daryl M Okamura; Abiodun Omoloja; Mahmoud Kallash; William E Smoyer; Guillermo Hidalgo; Scott E Wenderfer
Journal:  Pediatr Nephrol       Date:  2022-03-28       Impact factor: 3.651

Review 3.  Current Insights on Biomarkers in Lupus Nephritis: A Systematic Review of the Literature.

Authors:  Leonardo Palazzo; Julius Lindblom; Chandra Mohan; Ioannis Parodis
Journal:  J Clin Med       Date:  2022-09-28       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.